Incyte (INCY) Revenue (2010 - 2026)

Incyte (INCY) posted Revenue of $1.3 billion for Q1 2026, down 15.54% on a QoQ basis from $1.5 billion in Q4 2025, and up 20.87% year-over-year from $1.1 billion in Q1 2025.

Incyte (INCY) Revenue (2010 - 2026) Analysis & Trends

Incyte's Revenue history runs 17 years deep, the most recent figure standing at $1.3 billion for Q1 2026.

  • Quarterly Revenue rose 20.87% year-over-year to $1.3 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.4 billion (up 21.48% YoY) and the FY2025 annual result came in at $5.1 billion, up 21.22% from the prior year.
  • Revenue was $1.3 billion for Q1 2026 at Incyte, down from $1.5 billion in the prior quarter.
  • Across five years, Revenue topped out at $1.5 billion in Q4 2025 and bottomed at $733.2 million in Q1 2022.
  • A 5-year average of $1.0 billion and a median of $1.0 billion in 2023 frame the typical range for Revenue.
  • Peak annual rise in Revenue reached 29.15% in 2022, while the deepest fall reached 1.27% in 2022.
  • Incyte's Revenue stood at $926.7 million in 2022, then rose by 9.35% to $1.0 billion in 2023, then increased by 16.32% to $1.2 billion in 2024, then rose by 27.84% to $1.5 billion in 2025, then dropped by 15.54% to $1.3 billion in 2026.
  • Business Quant data shows INCY's Revenue at $1.3 billion in Q1 2026, $1.5 billion in Q4 2025, and $1.4 billion in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 1.51 Bn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 2.99 Bn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 3.61 Bn
7 Belite Bio 61.40 Bn 61.40 Bn - -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn 1.30 Bn
9 Revolution Medicines 37.37 Bn 37.37 Bn - -
10 Incyte 23.47 Bn 19.46 Bn 1.17 Bn 1.27 Bn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.27 Bn
Dec 31, 2025 1.51 Bn
Sep 30, 2025 1.37 Bn
Jun 30, 2025 1.22 Bn
Mar 31, 2025 1.05 Bn
Dec 31, 2024 1.18 Bn
Sep 30, 2024 1.14 Bn
Jun 30, 2024 1.04 Bn
Mar 31, 2024 880.89 Mn
Dec 31, 2023 1.01 Bn
Sep 30, 2023 919.03 Mn
Jun 30, 2023 954.61 Mn
Mar 31, 2023 808.67 Mn
Dec 31, 2022 926.70 Mn
Sep 30, 2022 823.30 Mn
Jun 30, 2022 911.40 Mn
Mar 31, 2022 733.24 Mn
Dec 31, 2021 862.85 Mn
Sep 30, 2021 812.99 Mn
Jun 30, 2021 705.71 Mn